日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Short-course subcutaneous treatment with birch pollen allergoids greatly improves symptom and medication scores in birch allergy

短期皮下注射桦树花粉过敏原可显著改善桦树过敏的症状和用药评分。

Mösges, Ralph; Raskopf, Esther; Klimek, Ludger; Pfaar, Oliver; Zielen, Stefan; Xenofontos, Elena; Decker, Lea; Neuhof, Christian; Rybachuk, Anna; Acikel, Cengizhan; Sahin, Hacer; Allekotte, Silke; Del Pozo Collado, Sandra; Subiza, José Luis; Casanovas, Miguel; Cuevas, Mandy

Allergen Immunotherapy with Depigmented-Polymerised Cat Allergoid Is Safe and Well-Tolerated in Patients with Allergic Rhinitis/Rhinoconjunctivitis

使用脱色聚合猫过敏原进行过敏原免疫疗法治疗过敏性鼻炎/鼻结膜炎患者安全且耐受性良好。

Mösges, Ralph; Rybachuk, Anna; Curtius, Edmund; Acikel, Cengizhan; Drevermann, Anne; Werkhäuser, Nina; Sahin, Hacer; Katzke, Nadine; Allekotte, Silke; Landmann, Ivo; Neumeyr, Daniela; Ticinelli, Eva-Cornelia; Sager, Angelika

Clinical Efficacy of One Short Course of Mannan-Conjugated Birch Pollen Allergoid Immunotherapy: A Comparative Evaluation After Prior Placebo Treatment

单疗程甘露聚糖偶联桦树花粉过敏原免疫疗法的临床疗效:与安慰剂治疗后的比较评价

Del Pozo, Sandra; Wahrhusen, Natascha; Pfaar, Oliver; Raskopf, Esther; Rybachuk, Anna; Acikel, Cengizhan; Sahin, Hacer; Allekotte, Silke; Subiza, José Luis; Casanovas, Miguel; Cuevas, Mandy; Mösges, Ralph

Correction: Gerstlauer et al. TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results. J. Clin. Med. 2025, 14, 2609

更正:Gerstlauer 等人,《TAPAS——一项针对季节性过敏性鼻炎儿童、青少年和成人的前瞻性、多中心、长期队列研究——设计和早期结果》,《临床医学杂志》,2025 年,14,2609。

Gerstlauer, Michael; Hiller, Julia; Raab, Jennifer; Birkholz, Katrin; Tapparo, Martin; Neuhof, Christian; Day, Laura; Rybachuk, Anna; Acikel, Cengizhan; Sahin, Hacer; Hebbeler, Kim; Becker, Sven; Vogelberg, Christian; Allekotte, Silke; Kramer, Matthias F; The Tapas Study Group

TAPAS-A Prospective, Multicentre, Long-Term Cohort Study in Children, Adolescents and Adults with Seasonal Allergic Rhinitis-Design and Early Results

TAPAS——一项针对儿童、青少年和成人季节性过敏性鼻炎患者的前瞻性、多中心、长期队列研究——设计和早期结果

Gerstlauer, Michael; Hiller, Julia; Raab, Jennifer; Birkholz, Katrin; Tapparo, Martin; Neuhof, Christian; Day, Laura; Rybachuk, Anna; Acikel, Cengizhan; Sahin, Hacer; Hebbeler, Kim; Becker, Sven; Vogelberg, Christian; Allekotte, Silke; Kramer, Matthias F; The Tapas Study Group

Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer

更正:PARP靶向Auger发射体疗法采用[(125)I]PARPi-01治疗三阴性乳腺癌

Sankaranarayanan, Ramya Ambur; Florea, Alexandru; Allekotte, Susanne; Vogg, Andreas T J; Maurer, Jochen; Schäfer, Laura; Bolm, Carsten; Terhorst, Steven; Classen, Arno; Bauwens, Matthias; Morgenroth, Agnieszka; Mottaghy, Felix M

Correlation of the combined symptom and medication score with quality of life, symptom severity and symptom control in allergic rhinoconjunctivitis

过敏性鼻结膜炎中症状和药物综合评分与生活质量、症状严重程度和症状控制的相关性

Palathumpattu, Binoy; Pieper-Fürst, Ursula; Acikel, Cengizhan; Sahin, Hacer; Allekotte, Silke; Singh, Jaswinder; Hess, Mark; Sager, Angelika; Müller, Thomas; Mösges, Ralph

PARP targeted Auger emitter therapy with [125I]PARPi-01 for triple-negative breast cancer

PARP 靶向俄歇发射体疗法联合 [125I]PARPi-01 治疗三阴性乳腺癌

Ramya Ambur Sankaranarayanan, Alexandru Florea, Susanne Allekotte, Andreas T J Vogg, Jochen Maurer, Laura Schäfer, Carsten Bolm, Steven Terhorst, Arno Classen, Matthias Bauwens, Agnieszka Morgenroth, Felix M Mottaghy

A meta-analysis on allergen-specific immunotherapy using MCT(®) (MicroCrystalline Tyrosine)-adsorbed allergoids in pollen allergic patients suffering from allergic rhinoconjunctivitis

一项关于使用MCT®(微晶酪氨酸)吸附的过敏原进行过敏原特异性免疫疗法治疗花粉过敏性鼻结膜炎患者的荟萃分析

Becker, Sven; Zieglmayer, Petra; Canto, Gabriela; Fassio, Filippo; Yong, Patrick; Acikel, Cengizhan; Raskopf, Esther; Steveling-Klein, Esther Helen; Allekotte, Silke; Mösges, Ralph

Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season

在第一个花粉季,使用含有树木过敏原的舌下免疫疗法滴剂进行缩短剂量递增疗程耐受性良好,并能产生剂量依赖性的临床疗效。

Mösges, Ralph; Breitrück, Nils Y; Allekotte, Silke; Shah-Hosseini, Kija; Dao, Van-Anh; Zieglmayer, Petra; Birkholz, Katrin; Hess, Mark; Bastl, Maximilian; Bastl, Katharina; Berger, Uwe; Kramer, Matthias F; Guethoff, Sonja